With the evolving industrialization of life sciences, many companies are looking to capitalize on growth opportunities and proactively manage their capital structures. Such objectives often require accessing capital markets in the form of a public offering. Done properly, an IPO not only supports a company’s corporate strategy, but also transforms the lives of everyone involved (owners, board, employees and investors).
Please join us on December 6 to hear our group of speakers discuss how to best prepare for and execute a successful IPO, as well as adjust to life post-IPO. In this seminar, panelists will explore the current regulatory environment, market trends and the preparation necessary to ensure readiness, as well as the transition and long-term effects of becoming a public company.
3:00–5:00 PM | Conference
5:00–6:30 PM | Victory Brewing - Beer/Wine Tasting and Food Pairings
Rachael M. Bushey, Partner, Chair of Life Sciences, Pepper Hamilton
Jeff Ammerman, Managing Director, Healthcare Investment Banking,
Piper Jaffray & Co.
Roberto Cuca, Chief Financial Officer, OraSure Technologies
Thomas P. Hess, Chief Financial Officer, Genomind
Carolyn Saacke, Chief Operating Officer, Capital Markets, NYSE
Steve Simpson, Partner, EY
Life Sciences Pennsylvania
650 E. Swedesford Road - Suite 190
Wayne, PA 19087